Protegé Drug Eluting Balloon by Translumina is designed to support effective treatment of coronary artery disease and in-stent restenosis. Featuring advanced drug-delivery technology, it helps inhibit neointimal proliferation while maintaining vessel integrity without leaving a permanent implant behind. Engineered for precision, flexibility, and optimal deliverability, Protegé offers physicians a reliable solution for complex coronary interventions. Its innovative design contributes to improved clinical outcomes and enhanced patient care in interventional cardiology procedures.